“…Recently, dual-targeting delivery has been widely developed and played an important role in a variety of areas (Alpizar et al, 2011;Petkau et al, 2011;Yogev et al, 2011;Jackson et al, 2012), including cancer therapy (Shao et al, 2012;Xu et al, 2012). Which primary usually delivered anticancer drug to the diseased tissue, then to the tumors with some targeting moieties (Petkau et al, 2011).…”